Guaifenesin Pharmacokinetics Following Single‐Dose Oral Administration in Children Aged 2 to 17 Years

This study characterized guaifenesin pharmacokinetics in children aged 2 to 17 years (n = 40) who received a single oral dose of guaifenesin (age‐based doses of 100‐400 mg) 2 hours after breakfast. Plasma samples were obtained before and for 8 hours after dosing and analyzed for guaifenesin using li...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Gary A., Solomon, Gail, Albrecht, Helmut H., Reitberg, Donald P., Guenin, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Pediatric Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066754/
https://www.ncbi.nlm.nih.gov/pubmed/26632082
http://dx.doi.org/10.1002/jcph.682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066754/
https://www.ncbi.nlm.nih.gov/pubmed/26632082
http://dx.doi.org/10.1002/jcph.682

Ejemplares similares